European Commission: Lack of alternatives to TiO2 precludes ban in drugs
Regulatory NewsJoanne S. Eglovitch
ComplianceEuropeExcipientsPharmaceuticalsProduct developmentQuality Assurance and ControlRegulatory Intelligence/PolicySupply Chain Management